Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (391-400 of 551) with videos related to

Pageof 56
Sort By:
Journal of Virology|September 16, 2006
Selection on the human immunodeficiency virus type 1 proteome following primary infectionYi Liu, John McNevin, Jianhong Cao, et al.
Current Opinion in Virology|February 1, 2016
Selection of HIV vaccine candidates for concurrent testing in an efficacy trialYing Huang, Carlos DiazGranados, Holly Janes, et al.
The Journal of Experimental Medicine|July 1, 2017
Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivationTao Peng, R Savanh Chanthaphavong, Sijie Sun, et al.
Lancet (London, England)|November 18, 2008
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysisM Juliana McElrath, Stephen C De Rosa, Zoe Moodie, et al.
The Journal of Infectious Diseases|September 2, 2005
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjectsPaul A Goepfert, Helen Horton, M Juliana McElrath, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Li, Kerry J Laing, et al.
Nature Medicine|April 3, 2026
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's diseaseJeffrey L Cummings, Michael G Agadjanyan, Maureen Barry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
High Asymptomatic Carriage With the Omicron Variant in South AfricaNigel Garrett, Asa Tapley, Jessica Andriesen, et al.
The Journal of Clinical Investigation|September 24, 2020
CMV viral load kinetics as surrogate endpoints after allogeneic transplantationElizabeth R Duke, Brian D Williamson, Bhavesh Borate, et al.
Vaccine|September 7, 2023
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the USHong-Van Tieu, Shelly Karuna, Yunda Huang, et al.
Pageof 56

Showing results (391-400 of 551) with videos related to

Sort By:
Pageof 56
Journal of Virology|September 16, 2006
Selection on the human immunodeficiency virus type 1 proteome following primary infectionYi Liu, John McNevin, Jianhong Cao, et al.
Current Opinion in Virology|February 1, 2016
Selection of HIV vaccine candidates for concurrent testing in an efficacy trialYing Huang, Carlos DiazGranados, Holly Janes, et al.
The Journal of Experimental Medicine|July 1, 2017
Keratinocytes produce IL-17c to protect peripheral nervous systems during human HSV-2 reactivationTao Peng, R Savanh Chanthaphavong, Sijie Sun, et al.
Lancet (London, England)|November 18, 2008
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysisM Juliana McElrath, Stephen C De Rosa, Zoe Moodie, et al.
The Journal of Infectious Diseases|September 2, 2005
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjectsPaul A Goepfert, Helen Horton, M Juliana McElrath, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccineEmily S Ford, Alvason Li, Kerry J Laing, et al.
Nature Medicine|April 3, 2026
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's diseaseJeffrey L Cummings, Michael G Agadjanyan, Maureen Barry, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 30, 2022
High Asymptomatic Carriage With the Omicron Variant in South AfricaNigel Garrett, Asa Tapley, Jessica Andriesen, et al.
The Journal of Clinical Investigation|September 24, 2020
CMV viral load kinetics as surrogate endpoints after allogeneic transplantationElizabeth R Duke, Brian D Williamson, Bhavesh Borate, et al.
Vaccine|September 7, 2023
Safety and immunogenicity of a recombinant oligomeric gp145 subtype C Env protein (gp145 C.6980) HIV vaccine candidate in healthy, HIV-1-uninfected adult participants in the USHong-Van Tieu, Shelly Karuna, Yunda Huang, et al.
Pageof 56